Targacept leverages its scientific leadership and proprietary drug discovery platform Pentad? fuel its pipeline and attract significant collaborations with global pharmaceutical companies. For more information, please visit.. Will be accessible to a live audio webcast of the call to ensure the Investor Relations page of Targacept ‘s website to order a timely connection to the webcast, it is recommended that users minutes after minutes before register scheduled start time. An archived version of the webcast will. On the Investor Calendar section of the Investor Relations page of Targacept website for at least two weeks after the call About Targacept Targacept is developing a diverse pipeline of innovative NNR Therapeutics? for difficult to treat diseases and disorders of the nervous system.

General and administrative expenses totaled 000 for the second quarter and six months ended 30 June 2012, respectively.With News Reporter Staff News Editor at pharmaceutical Business Week Targacept, Inc. ? A clinical-stage biopharmaceutical company developing novel NNR Therapeutics, announced financial results for the second quarter and the first six months 30, 2012 .licensor I share the great frustration for many women about the delays in Herceptin I am determined to to take measures, and this is a major step forward in our fight against cancer. .

.

Other Posts From Category "tools":

Related Posts